View Author
women lesion cancer hrhpv study testing group result cytology screening papillomaviru month cin 2/3 lesions follow-up cin grade 2 grade treatment methylation number infection colposcopy expression vaccine hrhpv testing patient netherland vaccination hpv dna testing table round 24 months detection disease university vu university control cytological trial prophylactic 2/3 /recurrent cin baseline cin 3+ lesions post-treatment carcinoma analysis meijer cj meijer control group rozendaal l cervix protein prophylactic hpv vaccination region snijder hpv testing colposcopic snijders pj cin grade 3 center hpv 16 pathology cohort intervention group department value prophylactic vaccination 5- year risk sensitivity promoter 16ink prostate speci ficity gynecol tumor cytokine adenocarcinoma /recurrent smear cin 3+
10 Most Recent Publications
|
HrHPV-testing in a university hospital gynecology outpatient clinic: Recommendations for clinical practice
(Article)
Louwers, J.A. Berkhof, J. Zaal, A. Kocken, M. Rozendaal, L. Heideman, D.A.M. Baal, W.M. van Snijders, P.J.F. Verheijen, R.H.M. Meijer, C.J.L.M. |
2012-03-01
|
|
High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix
(Article)
Kocken, M. Baalbergen, A. Snijders, P.J.F. Bulten, J. Quint, W.G.V. Smedts, F. Meijer, C.J.L.M. Helmerhorst, T.J.M. |
2011-08-01
|
|
Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: A long-term multi-cohort study
(Article)
Kocken, M. Helmerhorst, T.J.M. Meijer, C.J.L.M. Berkhof, J. Louwers, J.A. Nobbenhuis, M.A.E. Bais, A.G. Hogewoning, C.J.A. Zaal, A. Verheijen, R.H.M. Snijders, P.J.F. |
2011-05-01
|
|
Dynamic spectral imaging colposcopy: Higher sensitivity for detection of premalignant cervical lesions
(Article)
Louwers, J.A. Zaal, A. Meijer, C.J.L.M. Kemenade. F.J. van Verheijen, R.H.M. Kocken, M. Harmsel, W.A. ter Graziosi, G.C.M. Spruijt, J.W.M. Berkhof, J. Balas, C. Papagiannakis, E. Snijders, P.J.F. |
2011-02-01
|
|
Colposcopic characteristics of high-risk human papillomavirus-related cervical lesions
(Article)
Louwers, J.A. Kocken, M. Bijl, J.C. van der Berkhof, J. Snijders, P.J.F. Meijer, C.J.L.M. Verheijen, R.H.M. |
2010-01-01
|
|
Post-treatment CIN: Randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease
(Article)
Bais, A.G. Eijkemans, M.J.C. Rebolj, M. Snijders, P.J.F. Verheijen, R.H.M. Ballegooijen, M. van Meijer, C.J.L.M. |
2009-02-15
|
|
Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas
(Article)
Wilting, S.M. Steenbergen, R.D.M. Ylstra, B. Meijer, C.J.L.M. Snijders, P.J.F. Tijssen, M. Wieringen, W.N. Helmerhorst, T.J.M. Kemenade, F. van Bleeker, M.C.G. Wiel, M.A. van de Carvalho, B. Meijer, G.A. |
2009-01-15
|
|
Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC
(Article)
Overmeer, R.M. Henken, F.E. Meijer, C.J.L.M. Steenbergen, R.D.M. Snijders, P.J.F. Claassen-Kramer, D. Berkhof, J. Helmerhorst, T.J.M. Heideman, D.A.M. Wilting, S.M. Murakami, Y. Ito, A. |
2008-08-01
|
|
Vaccination against HPV: Indications for women and the impact on the cervical screening programme
(Article)
Heideman, D.A.M. Snijders, P.J.F. Berkhof, J. Verheijen, R.H.M. Helmerhorst, T.J.M. Meijer, C.J.L.M. |
2008-07-01
|
|
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
(Article)
Bulkmans, N. Berkhof, J. Ruitinga, W. Ballegooijen, M. van Snijders, P.J.F. Meijer, C.J.L.M. Rozendaal, L. Kemenade, F. van Boeke, A. Bulk, S. Voorhorst, F. Verheijen, R. Groningen, K. van Boon, M. |
2007-11-24
|
